Liquidia (LQDA) Interest & Investment Income (2020 - 2026)
Liquidia (LQDA) posted Interest & Investment Income of $2.5 million for Q2 2026, up 39.73% on a QoQ basis from $1.8 million in Q1 2026, and up 56.31% year-over-year from $1.6 million in Q2 2025.
Analysis
Liquidia (LQDA) Interest & Investment Income (2020 - 2026) Analysis & Trends
Liquidia has reported Interest & Investment Income for 7 years, with the latest figure at $2.5 million in Q2 2026.
- On a quarterly basis, Interest & Investment Income rose 56.31% year-over-year to $2.5 million in Q2 2026; TTM through Jun 2026 was $7.6 million, a 4.55% increase from a year earlier, with the FY2025 full-year figure at $6.6 million, down 13.46% from the prior year.
- Interest & Investment Income was $2.5 million for Q2 2026 at Liquidia, up from $1.8 million in the prior quarter.
- The five-year high for Interest & Investment Income was $2.5 million in Q2 2026, with the low at $4000.0 in Q1 2022.
- Average Interest & Investment Income over 5 years is $1.3 million, with a median of $1.6 million recorded in 2025.
- The sharpest annual moves came in 2022 and 2023: Interest & Investment Income tumbled 80.95% in 2022, then soared 22950.0% in 2023.
- Over 5 years, Interest & Investment Income stood at $662000.0 in 2022, then jumped by 43.2% to $948000.0 in 2023, then soared by 121.94% to $2.1 million in 2024, then slipped by 20.77% to $1.7 million in 2025, then jumped by 48.53% to $2.5 million in 2026.
- The last three Interest & Investment Income figures came in at $2.5 million (Q2 2026), $1.8 million (Q1 2026), and $1.7 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.50 Bn | 622.74 Bn | 17.26 Bn | 219.00 Mn |
| 2 | AbbVie | 440.29 Bn | 433.72 Bn | 12.70 Bn | -679.00 Mn |
| 3 | Merck | 364.93 Bn | 357.79 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.65 Bn | 258.96 Bn | 11.24 Bn | - |
| 5 | Pfizer | 158.92 Bn | 147.22 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.46 Bn | 45.08 Bn | 10.79 Bn | 89.50 Mn |
| 7 | Revolution Medicines | 44.32 Bn | 44.32 Bn | - | 35.58 Mn |
| 8 | Incyte | 25.32 Bn | 20.78 Bn | 1.57 Bn | 38.12 Mn |
| 9 | United Therapeutics | 21.42 Bn | 18.75 Bn | 683.80 Mn | 31.50 Mn |
| 10 | Liquidia | 6.09 Bn | 5.80 Bn | 160.92 Mn | 2.48 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.48 Mn |
| Mar 31, 2026 | 1.77 Mn |
| Dec 31, 2025 | 1.67 Mn |
| Sep 30, 2025 | 1.65 Mn |
| Jun 30, 2025 | 1.58 Mn |
| Mar 31, 2025 | 1.73 Mn |
| Dec 31, 2024 | 2.10 Mn |
| Sep 30, 2024 | 1.82 Mn |
| Jun 30, 2024 | 1.86 Mn |
| Mar 31, 2024 | 1.88 Mn |
| Dec 31, 2023 | 948,000.00 |
| Sep 30, 2023 | 862,000.00 |
| Jun 30, 2023 | 734,000.00 |
| Mar 31, 2023 | 922,000.00 |
| Dec 31, 2022 | 662,000.00 |
| Sep 30, 2022 | 359,000.00 |
| Jun 30, 2022 | 65,000.00 |
| Mar 31, 2022 | 4,000.00 |
| Dec 31, 2021 | 3,000.00 |
| Sep 30, 2021 | 4,000.00 |